Compare EIKN & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EIKN | PSNL |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.6M | 729.1M |
| IPO Year | N/A | 2019 |
| Metric | EIKN | PSNL |
|---|---|---|
| Price | $10.53 | $7.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $25.60 | $12.20 |
| AVG Volume (30 Days) | 301.9K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | N/A | $15.47 |
| Revenue Next Year | N/A | $39.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.76 | $2.83 |
| 52 Week High | $16.50 | $11.50 |
| Indicator | EIKN | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 44.70 |
| Support Level | N/A | $6.89 |
| Resistance Level | $16.34 | $7.78 |
| Average True Range (ATR) | 1.27 | 0.51 |
| MACD | -0.21 | 0.06 |
| Stochastic Oscillator | 6.15 | 47.69 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.